Inhibition of polyamine oxidase prevented cyclin-dependent kinase inhibitor-induced apoptosis in HCT 116 colon carcinoma cells

Apoptosis

Volumn 18, Issue 12, 2013, Pages 1536-1547

  Gürkan, Ajda Çoker ^a   Arisan, Elif Damla ^a   Obakan, Pinar ^a   Palavan Ünsal, Narçin ^a  

^a ISTANBUL KULTUR UNIVERSITY   (Turkey)

Author keywords

Apoptosis; CDK Inhibitors; Colon cancer; Polyamine catabolism

Indexed keywords

N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; POLYAMINE OXIDASE; PURVALANOL; ROSCOVITINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL POPULATION; CELL VIABILITY; COLON CARCINOMA; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASES; DOWN-REGULATION; HCT116 CELLS; HUMANS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYAMINES; PROTEIN KINASE INHIBITORS; PURINES;

EID: 84889096256     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-013-0885-8     Document Type: Article

References (45)

1. Duranton B, Holl V, Schneider Y et al (2002) Cytotoxic effects of the polyamine oxidase inactivator MDL 72527 to two human colon carcinoma cell lines SW480 and SW620. Cell Biol Toxicol 18:381-396
2. Benassi MS, Molendini L, Gamberi G et al (1999) Alteration of pRb/p16/cdk4 regulation in human osteosarcoma. Int J Cancer 84:489-493
3. King KL, Cidlowski JA (1995) Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 58:175-180
4. McClue SJ, Blake D, Clarke R et al (2002) In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine). Int J Cancer 102:463-468
5. Meijer L, Borgne A, Mulner O et al (1997) Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243:527-536
6. Mohapatra S, Chu B, Zhao X, Djeu J, Cheng JQ, Pledger WJ (2009) Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors. Int J Biochem Cell Biol 41:595-602
7. Wesierska-Gadek J, Gritsch D, Zulehner N, Komina O, Maurer M (2011) Roscovitine, a selective CDK inhibitor, reduces the basal and estrogen-induced phosphorylation of ER-α in human ER-positive breast cancer cells. J Cell Biochem 112:761-772
8. Zhang T, Jiang T, Zhang F et al (2010) Involvement of p21Waf1/Cip1 cleavage during roscovitine-induced apoptosis in non-small cell lung cancer cells. Oncol Rep 23:239-245
9. Raje N, Kumar S, Hideshima T et al (2005) Seliciclib (CYC202 or R-roscovitine), a small-molecule cyclin-dependent kinase inhibitor, mediates activity via down-regulation of Mcl-1 in multiple myeloma. Blood 106:1042-1047
10. Arisan ED, Coker A, Palavan-Unsal N (2012) Polyamine depletion enhances the roscovitine-induced apoptosis through the activation of mitochondria in HCT116 colon carcinoma cells. Amino Acids 42:655-665
11. Pegg AE, McCann PP (1982) Polyamine metabolism and function. Am J Physiol 243:C212-C221
12. Heby O, Persson L (1990) Molecular genetics of polyamine synthesis in eukaryotic cells. Trends Biochem Sci 15:153-158
13. Heby O, Andersson G, Gray JW (1978) Interference with S and G2 phase progression by polyamine synthesis inhibitors. Exp Cell Res 111:461-464
14. Andersson G, Heby O (1977) Kinetics of cell proliferation and polyamine synthesis during Ehrlich ascites tumor growth. Cancer Res 37:4361-4366
15. Morgan DML (1998) Polyamines: an introduction. In: Morgan DML (ed) Polyamine protocols. Humana Press, Clifton, pp 3-30
16. Hsu PC, Hung HC, Liao YF, Liu CC, Tsay GJ, Liu GY (2008) Ornithine decarboxylase attenuates leukemic chemotherapy drugs-induced cell apoptosis and arrest in human promyelocytic HL-60 cells. Leuk Res 32:1530-1540
17. Hu HY, Liu XX, Jiang CY et al (2005) Ornithine decarboxylase gene is overexpressed in colorectal carcinoma. World J Gastroenterol 11:2244-2248
18. Parchment RE, Pierce GB (1989) Polyamine oxidation, programmed cell death, and regulation of melanoma in the murine embryonic limb. Cancer Res 49:6680-6686
19. 1- acetyltransferase - the turning point in polyamine metabolism. Faseb J 7:653-661
20. 1-acetylated polyamine oxidase. J Biol Chem 278:20514-20525
21. 1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells. Mol Cancer Ther 6:128-137
22. Coker A, Arisan ED, Palavan-Unsal N (2012) Silencing of the polyamine catabolic key enzyme SSAT prevents CDK inhibitor-induced apoptosis in CaCo-2 colon cancer cells. Mol Med Rep 5:1037-1042
23. Garrofé-Ochoa X, Cosialls AM, Ribas J, Gil J, Boix J (2011) Transcriptional modulation of apoptosis regulators by roscovitine and related compounds. Apoptosis 16(7):660-670
24. Haan C, Behrmann I (2007) A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. J Immunol Methods 318:11-19
25. Senderowicz AM (2003) Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Cancer Chemother Pharmacol 52:S61-S73
26. Maurer M, Komina O, Wesierska-Gadek J (2009) Roscovitine differentially affects asynchronously growing and synchronized human MCF-7 breast cancer cells. Ann N Y Acad Sci 1171:250-256
27. Villerbu N, Gaben AM, Redeuilh G, Mester J (2002) Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities. Int J Cancer 97:761-769
28. Abaza MS, Bahman AM, Al-Attiyah RJ (2008) Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells. World J Gastroenterol 14:5162-5175
29. Wesierska-Gadek J, Gueorguieva M, Wojciechowski J, Horky M (2004) Cell cycle arrest induced in human breast cancer cells by cyclin-dependent kinase inhibitors: a comparison of the effects exerted by roscovitine and olomoucine. Pol J Pharmacol 56:635-641
30. Wesierska-Gadek J, Wandl S, Kramer MP, Pickem C, Krystof V, Hajek SB (2008) Roscovitine up-regulates p53 protein and induces apoptosis in human HeLaS(3) cervix carcinoma cells. J Cell Biochem 105:1161-1171
31. Knockaert M, Lenormand P, Gray N, Schultz P, Pouyssegur J, Meijer L (2002) p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol. Oncogene 21:6413-6424
32. Herr I, Debatin KM (2001) Cellular stress response and apoptosis in cancer therapy. Blood 98:2603-2614
33. Hahntow IN, Schneller F, Oelsner M et al (2004) Cyclin-dependent kinase inhibitor roscovitine induces apoptosis in chronic lymphocytic leukemia cells. Leukemia 18:747-755
34. Rosato RR, Almenara JA, Maggio SC et al (2005) Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells. Mol Cancer Ther 4:1772-1785
35. Hamana K, Matsuzaki S (1992) Polyamines as a chemotaxonomic marker in bacterial systematics. Crit Rev Microbiol 18:261-283
36. McGarrity TJ, Peiffer LP, Bartholomew MJ, Pegg AE (1990) Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas. Cancer 66:1539-1543
37. Pegg AE (1988) Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48:759-774
38. Devens BH, Weeks RS, Burns MR, Carlson CL, Brawer MK (2000) Polyamine depletion therapy in prostate cancer. Prostate Cancer Prostatic Dis 3:275-279
39. Kramer DL, Chang BD, Chen Y et al (2001) Polyamine depletion in human melanoma cells leads to G1 arrest associated with induction of p21WAF1/CIP1/SDI1, changes in the expression of p21-regulated genes, and a senescence-like phenotype. Cancer Res 61:7754-7762
40. Casero RA Jr, Woster PM (2001) Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 44:1-26
41. 1-acetyltransferase in a human large cell lung carcinoma. Biochem J 270:615-620
42. Bolkenius FN, Bey P, Seiler N (1985) Specific inhibition of polyamine oxidase in vivo is a method for the elucidation of its physiological role. Biochim Biophys Acta 838:69-76
43. Hu RH, Pegg AE (1997) Rapid induction of apoptosis by deregulated uptake of polyamine analogues. Biochem J 328:307-316
44. Ha HC, Woster PM, Yager JD, Casero RA Jr (1997) The role of polyamine catabolism in polyamine analogue-induced programmed cell death. Proc Natl Acad Sci USA 94:11557-11562
45. Dai H, Kramer DL, Yang C, Murti KG, Porter CW, Cleveland JL (1999) The polyamine oxidase inhibitor MDL-72,527 selectively induces apoptosis of transformed hematopoietic cells through lysosomotropic effects. Cancer Res 59:4944-4954